In a significant shift that has sent ripples throughout the journalism community, Jeff Bezos, the founder of Amazon and owner of The Washington Post, announced that the newspaper’s opinion pages will now be exclusively dedicated to promoting “personal liberties and free markets.” This declaration, made in an email to Post staff shared on X (formerly
Business
In the face of an increasingly competitive and unpredictable automotive market, General Motors (GM) is taking robust steps to maintain investor confidence and enhance share value. Recently, the company announced a significant increase in its quarterly dividend and launched a substantial share repurchase program aimed at rewarding shareholders while navigating the complexities of slowing sales
Eli Lilly is making headlines this week by introducing higher doses of its popular weight loss drug, Zepbound, in single-dose vials at significantly lower prices. This move is particularly aimed at making the medication accessible to patients without insurance coverage— a crucial step, especially for those enrolled in Medicare. The company’s proactive strategy comes in
In a recent interview with CNBC, Jamie Dimon, the CEO of JPMorgan Chase, spotlighted a significant issue regarding the operational effectiveness of the U.S. government. During the conversation, he evaluated the impact of the current administration’s policies on federal employment and efficiency. Dimon articulated a crucial point: the government is fundamentally dysfunctional, and this inefficiency
IMAX, a leader in large-format cinema, is poised for an exceptional year in 2024, with projections estimating a staggering $1.2 billion in box office revenue. This forecast, announced by CEO Rich Gelfond during a recent CNBC interview, hinges on a diverse and compelling film slate that promises to attract viewers in droves. As the industry
The recent surge in family offices reflects a broader trend whereby wealth concentration among the rich is leading to innovative investment structures. As of now, estimates peg the number of family offices worldwide at around 8,000, entrusted with a staggering $3.1 trillion in assets, according to Deloitte. This financial evolution not only marks a shift
The recent announcement by the U.S. Food and Drug Administration (FDA) signaling the end of the two-year-long shortage of Novo Nordisk’s weight loss drug Wegovy and diabetes treatment Ozempic is a pivotal moment for both the pharmaceutical landscape and the hundreds of thousands of patients who depend on these medications. With the margins on these
In a significant departure from tradition, the New York Yankees have decided to lift their long-standing ban on beards, a policy that has been in place for nearly five decades. Owner Hal Steinbrenner announced this monumental change after discussions with both current and former players, indicating a willingness to adapt to the evolving culture of
UnitedHealthcare, the behemoth of the American health insurance sector, continues to find itself embroiled in a series of challenges that could reshape its future. As the company navigates an ongoing investigation by the government into its Medicare Advantage billing practices, the atmosphere within the company is thick with uncertainty. Coupled with mounting tensions involving high-profile
In a dramatic shift, Bluebird Bio, once hailed as a pioneering leader in the field of gene therapy, is selling itself to private equity firms Carlyle and SK Capital for around $30 million. This move signifies an unfortunate culmination of a series of setbacks that rendered the company nearly bankrupt, prompting the end of its